Zantac / Ranitidine (NDMA Cancer) Attorney in Cleveland, Ohio

Zantac Litigation in Cleveland

Cleveland's world-class medical infrastructure — centered on Cleveland Clinic and UH Seidman Cancer Center — provides exceptional cancer documentation for Zantac claimants. The Taussig Cancer Institute's comprehensive oncology records, tumor boards, and multidisciplinary reviews produce detailed cancer documentation that is highly valuable in pharmaceutical litigation. Ohio applies Daubert under Ohio R. Evid. 702. Cleveland-area claimants should consult national plaintiffs' counsel about Delaware Superior Court filing. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Cleveland Zantac Claimants

Cleveland-area Zantac claimants should gather pharmacy records from Giant Eagle, Marc's, CVS, and Walgreens pharmacies. Cleveland Clinic Taussig Institute and UH Seidman Cancer Center records documenting bladder, esophageal, stomach, or colorectal cancer staging and treatment are among the most comprehensive available. Ohio's 2-year SOL requires prompt legal consultation with qualified Zantac plaintiffs' counsel.